Tustin, CA, United States of America

Robert L Wolfert

This inventor holds 1 USPTO granted patent. Top assignee: Atairgin Technologies, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert L Wolfert. Retrieved from https://idiyas.com/inventor/robert-l-wolfert-2s9onadb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Robert L. Wolfert

Introduction

Robert L. Wolfert is a notable inventor based in Tustin, California. He has made significant contributions to the field of medical diagnostics, particularly in the detection of carcinomas. His innovative approach has the potential to improve early detection and treatment outcomes for patients.

Latest Patents

Robert L. Wolfert holds a patent for a method of detecting carcinomas. This invention relates to measuring the level of a glycerol compound, such as glycerol-3-phosphate, in plasma, serum, or urine specimens from patients. The method is particularly useful as a screening test for ovarian and breast carcinomas, providing a valuable tool for early diagnosis.

Career Highlights

Wolfert is associated with Atairgin Technologies, Inc., where he applies his expertise in developing advanced diagnostic methods. His work has been instrumental in pushing the boundaries of medical technology and improving patient care.

Collaborations

Throughout his career, Robert has collaborated with talented individuals such as Timothy R. Compton and Jeff A. Parrott. These partnerships have fostered innovation and contributed to the success of his projects.

Conclusion

Robert L. Wolfert's contributions to the field of medical diagnostics exemplify the impact of innovative thinking in healthcare. His patented method for detecting carcinomas represents a significant advancement in early cancer detection, showcasing the importance of research and development in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…